Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Study shows prostate brachytherapy using ‘Radioactive Seeds’ is an effective alterantive to surgery or external radiation

Radiation oncologists and urologists at The Cleveland Clinic have performed their 1,000th prostate brachytherapy, a type of treatment in which radioactive seeds are implanted in the prostate to destroy cancerous cells.

28 Apr 2004

Exercise provides therapeutic benefits, such as easing fatigue during radiation treatments

Doctors have known for quite awhile that exercise plays a role in preventing some cancers. But in a new twist, a researcher at the James C. Wilmot Cancer Center is studying whether exercise provides therapeutic benefits, such as easing fatigue during radiation treatments.

28 Apr 2004

The world's smallest computer made entirely of biological molecules

The world's smallest computer (around a trillion can fit in a drop of water) might one day go on record again as the tiniest medical kit.

28 Apr 2004

Sprouts and broccoli may reduce risk of high blood pressure

Glucoraphanin, also known as sulforaphane glucosinolate (SGS(TM)), a naturally-occurring compound found in broccoli sprouts and broccoli, may reduce risk of high blood pressure, cardiovascular disease and stroke, according to new research published in the May 4 issue of the Proceedings of the National Academy of Sciences of the USA.

28 Apr 2004

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.

28 Apr 2004

How to beat throat cancer

Rochesterian Jim Toole is looking forward to a warm summer filled with hearty picnic barbecues after beating throat cancer.

16 Apr 2004

Certain prostate cancer cell lines are unable to repair DNA damage caused by "free radicals"

16 Apr 2004

Cancer rates have decreased in men and remained stable in women

Data newly compiled by the American Cancer Society finds death rates for most major cancers continue to decline, but a growing and aging population continues to produce a rise in the total number of cancer deaths.

14 Apr 2004

Spike TV launches men's health campaign with National Medical Association

As part of Spike TV's mission to make a difference in men's lives, the network announces the launch of "Check Up or Check Out," a national pro-social campaign directed at improving men's health. The campaign was launched today with Spike TV's "Check Up or Check Out" campaign with Randall W. Maxey, M.D., Ph.D,. President of the National Medical Association.

13 Apr 2004

Men with family history of prostate cancer accurately predict higher risk

When a man is diagnosed with prostate cancer, his brothers are twice as likely to develop the disease as well, often at an earlier age.

13 Apr 2004

New online prostate calculator

A study just completed by researchers at the Josephine Ford Cancer Center has resulted in the most comprehensive long-term prostate cancer survival model available to date. An interactive version of the survival model is available online at prostatecalculator.org.

12 Apr 2004

Vitamin E appears to cut in half people's risk of bladder cancer

Getting plenty of vitamin E by eating foods like nuts and olive oil appears to cut in half people's risk of bladder cancer, the fourth leading cancer killer among men, a new study suggests.

12 Apr 2004

Kentucky's first robotic procedure treats prostate

Earlier this year, the University of Kentucky Hospital was the first hospital in Kentucky to perform a minimally invasive, coronary artery bypass graft using surgical robotic instruments.

12 Apr 2004

Latest developments in prostate cancer research

New research on genes linked to hereditary prostate cancer helps scientists better understand how prostate cancer grows. Tests to find abnormal prostate cancer genes could also help tell which men are at high risk. They could then be tested more often. Further research could provide answers about the chemical changes that lead to prostate cancer. Then, perhaps, we could design drugs to reverse those changes.

12 Apr 2004

Study suggests ways to prevent prostate cancer

Current information on prostate cancer risk factors suggests that some cases might be prevented. One possible risk factor that can be changed is diet. You may be able to reduce your risk of prostate cancer by changing the way you eat.

11 Apr 2004

DNA free radical damage research

Certain prostate cancer cell lines are unable to repair DNA damage caused by "free radicals," according to scientists at the National Institute of Standards and Technology (NIST) and National Institutes of Health (NIH). This type of damage has been implicated before in the development of prostate cancer, but the new research provides the first solid evidence that the normal repair process is altered in prostate cancer cells, possibly leading to a cascade of events that culminate in further DNA damage and cellular dysfunction.

9 Apr 2004

Study shows frequent masturbation reduces chance of developing prostate cancer

An Amercian study has shown sexual activity has been hypothesized to play a role in the development of prostate cancer, but epidemiological data are virtually limited to case-control studies, which may be prone to bias because recall among individuals with prostate cancer could be distorted as a consequence of prostate malignancy or ongoing therapy.

7 Apr 2004

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent

NeoRx Corporation today announced that it has acquired from AnorMED Inc. the worldwide exclusive rights, excluding Japan, to develop, manufacture and commercialize AMD473, a platinum-based anti-cancer agent. AMD473 has been administered to more than 500 cancer patients in phase I and phase II clinical trials, demonstrating anti-cancer activity in a wide range of tumors and a manageable safety profile. NeoRx expects to initiate clinical studies of AMD473 in one or more cancer indications in the second half of this year.

5 Apr 2004

Discovery of novel gene profile that may identify colon stem cells

Researchers at Jefferson Medical College have uncovered a novel pattern of gene expression in the stem cell-rich bottom of tiny “crypts” in the tissue lining the colon. By identifying these patterns, the scientists hope to be able to identify mechanisms through which stem cells contribute to the development of colon cancer.

30 Mar 2004

Data on pre-clinical activity of satraplatin in prostate cancer to be released

Spectrum Pharmaceuticals, Inc has announced that new data on pre-clinical activity of satraplatin in prostate cancer cell lines are being presented at the 95th Annual Meeting of the American Association for Cancer Research (AACR) in Orlando, Florida.

29 Mar 2004